Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression

Volume 11, Issue 1, December 2022 .

Source: OncoImmunology - March 21, 2022 Category: Cancer & Oncology Authors: Donghwan Jeon Douglas G. McNeel Source Type: research